IMPORTANT SHAREHOLDER DEADLINE ALERT – ORMAT

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
419
IMPORTANT SHAREHOLDER DEADLINE ALERT – ORMAT TECHNOLOGIES, INC.: Investors with Losses in Excess of $100,000 are Encouraged to Contact Kaskela Law LLC

RADNOR, Pa., June 18, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC notifies Ormat Technologies, Inc. (NYSE: ORA ) (“Ormat” or the “Company”) investors that a class action complaint has been filed on behalf of investors who purchased the Company’s common stock between August 8, 2017 and May 15, 2018 , inclusive (the “Class Period”).

IMPORTANT DEADLINE ALERT:   Investors who purchased Ormat common stock during the Class Period may, no later than August 10, 2018 , seek to be appointed as a lead plaintiff representative of the investor class.  Ormat investors are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740 for additional information or to discuss their important legal rights and options.  Ormat investors may also submit their information at www.kaskelalaw.com/case/ormat . 

On May 11, 2018, Ormat reported that it was “not able to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2018” due to “an error in the Company’s financial statement presentation of deferred income tax assets and deferred income tax liabilities that affects the Company’s balance sheets in previous reporting periods.”  Following this news, shares of the Company’s stock fell $3.42 per share, or over 6%, to close on May 14, 2018 at $52.77, on heavy trading volume.

Then on May 16, 2018, Ormat’s common stock further declined after the Company disclosed that it would “restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements,” and warned that “investors should no longer rely upon the Company’s previously issued financial statements for the periods set forth above, earnings releases for these periods, and other communications relating to these financial statements.” 

The shareholder class action complaint alleges, among other things, that Ormat and certain other defendants made false and misleading statements and/or failed to disclose to investors that the Company’s financial statements contained material errors.  The complaint further alleges that, as a result of the foregoing, investors purchased Ormat’s common stock at artificially inflated prices during the Class Period and suffered investment losses following the Company’s disclosures.

Ormat investors are encouraged to contact Kaskela Law LLC (David Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or via www.kaskelalaw.com/case/ormat , for additional information or to discuss their legal rights and options. 

Kaskela Law LLC exclusively prosecutes shareholder actions in state and federal courts throughout the country on behalf of investors.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com .

CONTACT:

KASKELA LAW LLC David Seamus Kaskela, Esq. 201 King of Prussia Road Suite 650 Radnor, PA 19087 (484) 258 – 1585 (888) 715 – 1740 skaskela@kaskelalaw.com www.kaskelalaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading